Venus Concept Shares Surge

Shares of Venus Concept Co., Ltd. (NASDAQ:Bello) skyrocketed by over 500% on Friday.

Trading Volume Boom

The stock experienced a remarkable trading volume of 223.09 million shares, significantly higher than its average of 1.74 million shares, according to Benzinga Pro Data.

Shareholder Update

Madeline Asset Management disclosed a 91% ownership stake in the medical beauty technology firm. In an SEC filing on Friday, they indicated that this move was intended for investment.

As a major shareholder, the alternative asset management firm has been, and plans to remain, actively involved with the company’s operational, financial, and strategic choices, including exploring potential strategic options.

Madeline Asset Management focuses on investing in “innovative healthcare companies with unique products, technologies, and services,” as stated on their website.

In October 2025, the company converted $11.48 million in subordinated convertible notes held by Madeline into 545,335 shares of Series Y preferred stock.

Venus Concept Financial Snapshot

In the recent report for the third quarter, Venus Concept posted revenue of $13.78 million, which fell short of the $14.48 million consensus estimate. This 8% year-over-year decline and 12% decrease from the previous quarter were largely attributed to setbacks in their hair growth segment, reflecting delayed sales.

In November 2025, the FDA granted 510(k) clearance for Venus Concept’s Venus NOVA, a next-generation platform aimed at revolutionizing non-invasive body, face, and skin treatments.

Venus NOVA features an adaptive electrical muscle stimulation (EMS) integrated with multipolar radio frequency (RF) and pulsed electromagnetic fields (PEMF), along with advanced VariPulse technology for body contouring, muscle conditioning, skin treatment, and reduction of wrinkles and cellulite.

Price Action: Following Friday’s news, Venus Concept shares increased by 593.01%, reaching $9.91.